INTERNATIONAL PATENT: BEIJING STARMAB BIOMED TECHNOLOGY LTD, LIANG, YANBIN FILES APPLICATION FOR "MULTI-SPECIFIC CANCER-TARGETING ANTIBODIES"

GENEVA, May 19 -- BEIJING STARMAB BIOMED TECHNOLOGY LTD (Shengmingyuan Road, No. 29,Building 1, Room B213, Changping DistrictBeijing, Beijing 102206), LIANG, Yanbin (15375 Barranca Parkway, G104-105Irvine, California 92618) filed a patent application (PCT/US2024/054589) for "MULTI-SPECIFIC CANCER-TARGETING ANTIBODIES" on Nov 05, 2024. With publication no. WO/2025/101526, the details related to the patent application was published on May 15, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BEIJING STARMAB BIOMED TECHNOLOGY LTD (Shengmingyuan Road, No. 29,Building 1, Room B213, Changping Distri...